M6A RNA methylation in biliary tract cancer: the function roles and potential therapeutic implications

Xuesong Bai1, Jianhao Huang1, Yiqun Jin2

  • 1Department of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China.

Cell Death Discovery
|February 16, 2024
PubMed

Insights

N6-methyladenosine (m6A) regulators are crucial in biliary tract cancers (BTCs), influencing tumor development and drug resistance. Understanding these m6A alterations offers new avenues for targeted therapies and diagnostics in BTC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Biliary tract cancers (BTCs) are rare with poor prognoses, and current treatments for advanced stages are limited.
  • Understanding BTC molecular mechanisms is vital for developing effective targeted therapies.
  • N6-methyladenosine (m6A) is the most common RNA modification, often dysregulated in cancers.

Purpose of the Study:

  • To review the roles of m6A regulators in BTC tumorigenesis and progression.
  • To explore the functional impacts of m6A regulators on RNA metabolism in BTCs.
  • To highlight the potential of m6A modification as a target for novel BTC diagnostics and therapeutics.

Main Methods:

  • Literature review of studies on m6A regulators in BTC.
  • Analysis of m6A regulator functions in RNA processing (splicing, export, degradation, translation).
  • Synthesis of current knowledge on m6A's role in BTC development and drug resistance.

Main Results:

  • Aberrant m6A regulators act as oncogenes or tumor suppressors in BTC.
  • m6A modification influences RNA metabolism, impacting cancer progression.
  • Dysregulated m6A pathways are implicated in BTC tumorigenesis and therapeutic resistance.

Conclusions:

  • m6A regulators play significant roles in BTC pathogenesis.
  • Targeting m6A pathways presents a promising strategy for BTC treatment.
  • Further research into m6A modifications could lead to improved diagnostic and therapeutic approaches for BTC.

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.3K
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
187
RNA Stability01:53

RNA Stability

Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
33.5K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K